BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12648456)

  • 21. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
    Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
    Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population.
    Karnbach C; Daws MR; Niemi EC; Nakamura MC
    J Immunol; 2001 Sep; 167(5):2569-76. PubMed ID: 11509597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains.
    Matsuura A; Kinebuchi M; Chen HZ; Katabami S; Shimizu T; Hashimoto Y; Kikuchi K; Sato N
    J Immunol; 2000 Mar; 164(6):3140-8. PubMed ID: 10706704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production.
    Loza MJ; Metelitsa LS; Perussia B
    Eur J Immunol; 2002 Dec; 32(12):3453-62. PubMed ID: 12442327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of natural killer complex loci to the development of experimental cerebral malaria.
    Hansen DS; Ryg-Cornejo V; Ioannidis LJ; Chiu CY; Ly A; Nie CQ; Scalzo AA; Schofield L
    PLoS One; 2014; 9(4):e93268. PubMed ID: 24691125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
    Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
    J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
    Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
    J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
    Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
    J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
    J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
    Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
    J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
    Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
    Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses.
    Exley MA; Tahir SM; Cheng O; Shaulov A; Joyce R; Avigan D; Sackstein R; Balk SP
    J Immunol; 2001 Nov; 167(10):5531-4. PubMed ID: 11698421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1(+) T cells.
    Wilson EB; Parachoniak CA; Carpenito C; Mager DL; Takei F
    Immunogenetics; 2007 Aug; 59(8):641-51. PubMed ID: 17516061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
    Fiedler T; Walter W; Reichert TE; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.